0.25 mg Everolimus Tablets

Product Description

Backed by a diligent team of professionals, we have been able to provide 0.25 mg Everolimus Tablets, that are used to treat the symptoms of Breast Cancer, Renal Cell Carcinoma, Advanced Neuroendocrine Tumors and Renal Angiomyolipoma. These tablets are formulated using advance methodology in compliance with the set medical standards. Apart from this, our offered 0.25 mg Everolimus Tablets are available at market leading prices.